Trial and error
A new European Union directive looks set to shake up the insurance provisions in clinical and medical trials. Ana Paula Nacif looks at the remit of the new recommendations and assesses the likely side effects
Clinical and medical trials have entered a new phase since the implementation of a new European Union directive in May. Treading along the same lines as other EU initiatives, the directive has been
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe
You are currently unable to print this content. Please contact info@postonline.co.uk to find out more.
You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@postonline.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@postonline.co.uk
More on Regulation
FCA confirms AI review led by Mills
The Financial Conduct Authority has today (27 January) confirmed Sheldon Mills is to lead a review into the implications of advanced AI on consumers, retail financial markets and regulators.
FCA rejects calls for further Covid BI interventions
The Financial Conduct Authority has rejected calls for further interventions on Covid business interruption claims, sayings its current position “continues to be appropriate”.
What does 2026 have in store for claims professionals?
Trade Voice: John Bissell, executive director of the Charted Institute of Loss Adjusting, looks at the key topics that will dominate the claims agenda in 2026.
Are you ready to be stress tested by the PRA?
The regulator’s 2026 dynamic stress test will plunge insurers into a real-time, three-week crisis simulation unlike anything the sector has faced before, forcing firms to prove not just their capital strength but their ability to make rapid, data-driven decisions under pressure.
Unpicking the FCA’s decision to scrap CPD requirements
Trade Voice: Matthew Connell, director of policy and public affairs at the Chartered Insurance Institute, examines the FCA’s decision to scrap the requirement for insurance professionals to undertake a set amount of training each year.
Why insurers should be forced to signpost customers properly
Editor’s View: The Association of British Insurers and British Insurance Brokers’ Association’s signposting commitment is a step forward, but Emma Ann Hughes fears without rules and enforcement too many vulnerable consumers will still be left without access to cover.
PRA cuts frequency of meetings with insurers
The Prudential Regulation Authority has said it will cut the frequency of regular supervisory meetings with insurers in a Dear CEO letter published on Thursday.
Howden’s Kennedy says regulation may have ‘gone too far'
Howden UK & Ireland CEO Robert Kennedy has told Insurance Post he believes regulation has “gone too far” in certain places, and could be stifling innovation.